Invesco Mutual Fund announced the launch of Invesco India Pharma and Healthcare Fund on Tuesday. This is an open-ended equity scheme investing in pharma, healthcare and allied sectors.
The new fund offer or NFO of the fund is open for subscription and will close on September 1.
Also Read | HDFC Defence Fund adds Cochin Shipyard & INDO-MIM, increases stake in HAL, Mazagon Dock, 5 others
The fund seeks to capitalize on India's evolving healthcare ecosystem, shaped by favourable demographics, expanding healthcare access, rising insurance penetration, growing global pharmaceutical leadership, and emerging innovation-driven opportunities across healthcare and life sciences.
The scheme will invest across pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), medical devices, healthcare services, insurance and other allied healthcare segments.
India today occupies a unique position in the global healthcare ecosystem, supported by its scale, talent pool, manufacturing capabilities and growing innovation footprint. Structural drivers such as increasing healthcare expenditure, ageing demographics, rising lifestyle diseases, expanding health insurance coverage, infrastructure development and growing global outsourcing trends are expected to create long-term opportunities across the healthcare value chain.
The fund will be managed by Aditya Khemani and will be benchmarked against the BSE Healthcare TRI.
"India's healthcare sector is undergoing a structural transformation. The country is not only witnessing rising healthcare consumption driven by favourable demographics and increasing affordability but is also strengthening its position as a global pharmaceutical and healthcare innovation hub,” said Aditya Khemani, Head of Equity & Fund Manager, Invesco Mutual Fund.
“We see attractive opportunities across domestic pharma, hospitals, diagnostics, CDMOs and emerging healthcare segments that can potentially benefit from this multi-year growth cycle. Our investment approach will focus on identifying quality businesses with sustainable competitive advantages and strong growth visibility across the healthcare ecosystem,” Khemani further said.
The minimum lump sum investment amount during the NFO is Rs 1,000 and in multiples of Re 1 thereafter. For SIP investments, the minimum application amount is Rs 100 and in multiples of Re 1 thereafter.
Also Read | BSE, RIL, Paytm among stocks bought and sold by HDFC Mutual Fund in July
The fund will charge an exit load of 0.50% for units redeemed/switched out on or before 3 months from the date of allotment. No exit load will be charged if units are redeemed/switched out after 3 months.
( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
If you have any mutual fund queries, message on ET Mutual Funds on Facebook/Twitter. We will get it answered by our panel of experts. Do share your questions on ETMFqueries@timesinternet.in along with your age, risk profile, and Twitter handle
